Patients in Focus
A Closer Look at Real Patient Stories
We reached out to the following adult patients with moderate to severe RA, or moderate to severe UC who were prescribed XELJANZ after TNF blockers did not work well or could not be tolerated. Learn about their journeys on XELJANZ by exploring their stories below. Individual results may vary. Patient ambassador stories have been created in partnership with Pfizer.
Meet Olivia
Diagnosis: Moderate to severe rheumatoid arthritis
Olivia loves to be active, but it wasn’t always easy. In college, she experienced joint pain and swelling, and often had difficulty walking to class. After years of taking several treatments, including TNF blockers, she was ready to try something different.
The impact of XELJANZ
Olivia began to experience flare-ups, which included joint pain and swelling in her hands, when she was taking a TNF blocker. It wasn’t providing enough relief, so she asked her rheumatologist about other treatment options. They discussed the potential benefits and serious side effects and decided to try XELJANZ.
More days than not, the fact that I have RA does not weigh on my mind.
Since starting XELJANZ, Olivia has noticed an improvement in her RA symptoms. She has seen reduced joint pain and swelling and has an easier time completing daily tasks. She’s looking forward to enjoying activities that RA has made challenging in the past.
*Individual results may vary
-Olivia
Olivia in focus
Olivia is passionate about helping others with chronic conditions like hers. She’s currently pursuing a master’s degree in clinical psychology and is working with children. She also enjoys cooking and taking hikes with her friends.
Discover Support Resources
Take an active role in your treatment with tools and support resources—delivered directly to you. We’ll start by sending a Welcome Kit in the mail and will follow up with occasional emails containing timely information and lifestyle tips.
